双歧杆菌四联活菌片治疗慢性腹泻的临床疗效  

Clinical efficacy of Bifidobacterium quadruple viable tablets in the treatment of chronic diarrhea

作　　者：孙忠飞 SUN Zhong-fei(Department of Internal Medicine,Linghai People’s Hospital of Liaoning Province,Linghai 121200,China)

机构地区：[1]辽宁省凌海市人民医院内一科,121200

出　　处：《中国现代药物应用》2018年第18期89-91,共3页Chinese Journal of Modern Drug Application

摘　　要：目的分析双歧杆菌四联活菌片治疗慢性腹泻的临床疗效。方法 90例慢性腹泻患者,采用电脑随机分为观察组和对照组,每组45例。观察组患者实施双歧杆菌四联活菌片治疗,对照组患者实施常规治疗。对比两组患者不良反应发生情况、腹泻缓解时间。结果观察组患者不良反应发生率为6.67%,低于对照组患者的22.22%,差异具有统计学意义(P<0.05);观察组患者腹泻缓解时间为(5.21±1.02)d,短于对照组的(10.21±1.15)d,差异具有统计学意义(P<0.05)。结论对慢性腹泻患者实施双歧杆菌四联活菌片治疗能够取得显著效果,促进患者康复,减少患者不良反应,缩短患者症状改善时间,值得在进一步推广及运用。Objective To analyze the clinical efficacy of Bifidobacterium quadruple viable tablets in the treatment of chronic diarrhea.Methods A total of 90 patients with chronic diarrhea were randomly divided into observation group and control group by computers,45 cases in each group.Patients in the observation group were given Bifidobacterium quadruple viable tablets,patients in the control group were given conventional therapy.The adverse reactions and diarrhea remission time between the two groups were compared.Results The incidence of adverse reactions in the observation group was 6.67%,which was significantly lower than 22.22%in the control group,the difference was statistically significant(P<0.05).The remission time of diarrhea in the observation group was(5.21±1.02)d,which was significantly shorter than(10.21±1.15)d in the control group,the difference was statistically significant(P<0.05).Conclusion The treatment of Bifidobacterium quadruple viable tablets in the treatment of chronic diarrhea can achieve significant results,promote the rehabilitation of patients,reduce adverse reactions of patients,shorten patients’symptom improvement time,is worthy of further promotion and application.

关 键 词：双歧杆菌四联活菌片 慢性腹泻 临床疗效 

分 类 号：R574.62[医药卫生—消化系统]